Synthgene Overview
- Year Founded
-
2018
- Status
-
Private
- Employees
-
22
- Latest Deal Type
-
Later Stage VC
- Investors
-
14
Synthgene General Information
Description
Manufacturer of life sciences raw materials designed to support research and development in biotechnology and molecular medicine. The company offers nucleic acid drug materials, cell and gene therapy inputs, immunodiagnostic materials, and mRNA-related reagents supported by advanced platforms such as antibody discovery and enzyme evolution, enabling biotechnology companies, research institutions, and diagnostic developers to accelerate therapeutic development and improve research efficiency.
Contact Information
Website
www.syngenebio.comCorporate Office
- Building 7, Yiyao Health Technology Park, Number 63 Science and Technology Avenue
- Gaocheng Town, Yixing
- Wuxi, Jiangsu
- China
Corporate Office
- Building 7, Yiyao Health Technology Park, Number 63 Science and Technology Avenue
- Gaocheng Town, Yixing
- Wuxi, Jiangsu
- China
Synthgene Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 8. Later Stage VC | 23-Mar-2026 | Completed | Generating Revenue | |||
| 7. Later Stage VC (Series B1) | 26-Mar-2025 | Completed | Generating Revenue | |||
| 6. Secondary Transaction - Private | 20-Dec-2024 | Completed | Generating Revenue | |||
| 5. Later Stage VC (Series B) | 20-Dec-2024 | Completed | Generating Revenue | |||
| 4. Secondary Transaction - Private | 02-Jun-2023 | Completed | Generating Revenue | |||
| 3. Early Stage VC (Series A1) | 21-Mar-2022 | Completed | Generating Revenue | |||
| 2. Early Stage VC (Series A) | 21-Oct-2021 | $31M | $31M | Completed | Generating Revenue | |
| 1. Early Stage VC | 30-Jun-2021 | Completed | Generating Revenue |
Synthgene Patents
Synthgene Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026026951-A1 | Bvdv-ibrv bivalent mrna vaccine and use thereof | Pending | 02-Aug-2024 | ||
| WO-2025185690-A1 | Platinum compound and use thereof | Pending | 07-Mar-2024 | ||
| WO-2025185690-A8 | Platinum compound and use thereof | Pending | 07-Mar-2024 | ||
| WO-2025168058-A1 | Novel mrna capping compound and use thereof | Pending | 08-Feb-2024 | ||
| EP-4768492-A1 | Capping compound, and application thereof in mrna capping | Pending | 26-Sep-2023 | C07H19/207 |
Synthgene Signals
Synthgene Investors (14)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| S&G Investment | Venture Capital | Minority | ||
| Leader Venture Capital | Growth/Expansion | Minority | ||
| Granite Asia | Venture Capital | Minority | ||
| HaoYue Capital | Investment Bank | Minority | ||
| Suzhou Yuanfeng Capital Management | Government | Minority |
Synthgene Investments (1)
Synthgene’s most recent deal was a Early Stage VC with Xingchen Zhiyao. The deal was made on 17-Mar-2023.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Xingchen Zhiyao | 17-Mar-2023 | Early Stage VC | Drug Discovery |
Synthgene FAQs
-
When was Synthgene founded?
Synthgene was founded in 2018.
-
Where is Synthgene headquartered?
Synthgene is headquartered in Wuxi, China.
-
What is the size of Synthgene?
Synthgene has 22 total employees.
-
What industry is Synthgene in?
Synthgene’s primary industry is Biotechnology.
-
Is Synthgene a private or public company?
Synthgene is a Private company.
-
What is Synthgene’s current revenue?
The current revenue for Synthgene is .
-
How much funding has Synthgene raised over time?
Synthgene has raised $46.8M.
-
Who are Synthgene’s investors?
S&G Investment, Leader Venture Capital, Granite Asia, HaoYue Capital, and Suzhou Yuanfeng Capital Management are 5 of 14 investors who have invested in Synthgene.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process